13 julio 2015
Tumors can leverage glucose and another nutrient, acetate, to resist targeted therapies directed at specific cellular molecules, according to Ludwig Cancer Research scientists studying glioblastoma, a deadly brain cancer. The findings demonstrate that nutrients can strongly affect the signaling molecules that drive tumors.img src=»http://feeds.feedburner.com/~r/sciencedaily/~4/S9hf-1lP5wg» height=»1″ width=»1″ alt=»»/
http://feeds.sciencedaily.com/~r/sciencedaily/~3/S9hf-1lP5wg/150713161429.htm
